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The burden of disease from air pollution in




In an article recently published in the IJHPR, Ginsberg and colleagues from Israel’s Public Health Services estimate
the disease burden from airborne particulate matter in Israel. Using national data on the concentration of PM2.5
(particulate matter less than 2.5 μm in aerodynamic diameter) and risk estimates from meta-analyses, they calculate
that about 2000 deaths (4.7% of total deaths) are attributable to air pollution. Although inherently subject to
uncertainty, such estimates are useful for motivating public health protection and gauging the stringency of any
needed regulations. However, Israel does not yet have an evidence-based process for air quality regulation
comparable to that of the United States, which has evolved over the 45 years since passage of the Clean Air Act. In
fact, Israel has only recently promulgated a national standard for airborne particulate matter and quantitative risk
assessment has not been an element of regulatory decision-making. The report by Ginsberg and colleagues
represents a useful beginning and should initiate discussion of the role of burden estimation and risk assessment
more broadly in regulations intended to advance environmental health in Israel.
Background
In 1953, Morton Levin published a landmark paper that
described a measure that is widely known as the popula-
tion attributable risk, a parameter that gives an estimate
of the burden of disease attributable to a particular fac-
tor in a population [1]. At the time, the emerging litera-
ture on smoking and lung cancer had convinced Levin
that the relationship was causal. He reasoned that if a
factor caused a disease than an immediate question was
its overall importance as a cause, leading him to the for-
mula that is still used for this purpose. Application of
Levin’s formula requires specification of the exposure
and the associated risk for disease of that exposure and
also of a comparison or counterfactual exposure, reflect-
ing a theoretical minimum exposure that might be
achieved. In the example of cigarette smoking and lung
cancer, the values for these elements of Levin’s formula
are readily specified: there are many estimates of the
relative risk of lung cancer for smokers compared with
nonsmokers and the counterfactual comparison is
obvious—a smoking prevalence of zero. Thus, current
estimates of the fraction of lung cancer attributable to
smoking in high-income countries are around 85% per-
cent, given ever-smoking prevalence figures of about
30–40% and relative risk estimates of 20 and about 10
for current and former smokers, respectively, compared
with never smokers [2].
Many decades later and in an article which was re-
cently published in the IJHPR, Ginsberg and colleagues
[3] from Israel’s Public Health Services use the same
conceptual approach to estimate the disease burden
from airborne particulate matter in Israel. For ambient
or outdoor air pollution, the conceptual basis of the cal-
culation is similar to its application to smoking, but
there is greater uncertainty around the values for expos-
ure and risk compared with the case of cigarette smok-
ing. For exposure, Ginsberg et al. report that the 2015
mean concentration of PM2.5 (particulate matter less
than 2.5 μm in aerodynamic diameter) was 21.6 μg/m3;
this figure is applied to all residents of Israel, ignoring
the range of variation of actual exposures to particulate
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matter across the population. Another key matter is the
selection of a counterfactual value for Israel; on this
choice, the authors default to the World Health
Organization (WHO) methodology cited, which incor-
porates comparison values ranging from 5.8 to 8.8 μg/
m3 [4]. The choice of the counterfactual value is critical
in interpreting the findings: is it achievable? or, does it
represent a goal, such that the burden estimated exceeds
what might be achieved through practicable measures
for exposure reduction? For the United States, as the En-
vironmental Protection Agency has examined potential re-
vision of the National Ambient Air Quality Standard
(NAAQS) for ozone, there has been substantial co-
ntroversy concerning the appropriate counterfactual back-
ground concentration for risk assessment, given the
natural production of ozone and the long-range transport
of ozone into the United States [5]. For PM2.5, justification
of a particular counterfactual value for Israel is problem-
atic, given the country’s geography and the extent of pollu-
tion transport into the country. Thus, through air quality
management within the country, Israel may not be able to
reach the WHO counterfactual values through national
actions alone.
The other element of the calculation is the selection of
risk values for the adverse effects of air pollution; these
are in the form of percentage change in risk for disease
in relation to PM2.5 concentration. One challenge faced
by Ginsberg and colleagues was the selection of the risk
coefficients, which ideally would come from locally-
based investigations. The authors addressed this chal-
lenge, lacking locally generated estimates, by turning to
various systematic reviews and meta-analyses related to
air pollution and the associated risks for the specific dis-
eases for which burden was to be calculated. Their selec-
tion methods are described, although not with the detail
needed to replicate fully their approach. An important
issue is the generalizability of the findings of the risk es-
timates, which come from studies of populations outside
of Israel, to the population of Israel. This generalization
of the risk estimates is further complicated by the sub-
stantial diversity of the Israeli population. Meta-analyses
of epidemiological studies of the health effects of air pol-
lution generally show variation in risks among studies
[6]. Thus, the selection of particular risk estimates for
burden estimation is an inevitable and not readily quan-
tified source of uncertainty.
The approach taken by Ginsberg and colleagues devi-
ates from that used by the World Health Organization
and the Global Burden of Disease program (http://
www.healthdata.org/gbd). Burden estimates made by
these entities for the major disease outcomes are based on
so-called integrated exposure-response functions (IER) de-
veloped for ALRI (acute lower respiratory infections), lung
cancer, COPD (chronic obstructive pulmonary disease),
and cardiovascular disease. These IER functions are based
on a combined analysis of multiple relevant data sets; for
example, bringing together data on active and passive
smoking and air pollution for lung cancer, COPD and car-
diovascular disease [7]. In estimating global disease bur-
den, the IER risk relationships are applied uniformly
across all countries, potentially not appropriately captur-
ing risk for some countries.
How are burden estimates used?
The initial use of attributable risk calculation for
cigarette smoking established one paradigm for policy
application: use of burden estimates as an imperative for
action. In the United States, the burden of premature
death from active and passive smoking has been closely
tracked and served as a reminder of the need for sus-
tained and aggressive tobacco control. Burden estima-
tion has now become a global tool, used by the WHO
and the Global Burden of Disease (GBD) initiative at the
Institute for Health Metrics and Evaluation in the United
States [4, 8]. The GBD estimates have provided an under-
standing of the comparative importance of different con-
tributors to disease burden and changes in these
contributions over time. In the GBD 2013 estimates, am-
bient air pollution and household air pollution, have sur-
prising prominence; ambient air pollution accounts for 4.2
million attributable deaths or 12% of total deaths of dis-
ease burden while the count for household air pollution
is 2.9 million deaths or 5% of the total. There are an
additional 250,000 deaths attributable to ozone. For
Israel, the GBD estimate of attributable deaths for 2013
to ozone and particulate matter is 2250 or about 5% of
total deaths [8].
For decades, quantitative risk assessment has been
used for decision-making concerning environmental
hazards in the United States and elsewhere. As codified
in the “Red Book”, a 1983 report from the US National
Academy of Science, quantitative risk assessment has
four components: hazard identification (does an agent
pose a risk?), dose–response (how does risk vary with
exposure or dose?), exposure assessment (what is the
distribution of exposure to the agent?), and risk
characterization (what is the risk posed to the popula-
tion) [9]. The latter component is conceptually compar-
able to burden estimation as implemented by Ginsberg
and colleagues. As described below, quantitative risk as-
sessment is incorporated into the process used in the
United States for NAAQS revision.
Why have Ginsberg and colleagues, who work for
a national public health agency made estimates of
disease burden associated with ambient air pollution?
The estimates are offered with the rationale that
“Measuring the burden of disease from air pollution
is important not just for advocacy but also as a first
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step towards carrying out a full cost-effectiveness
analysis in order to prioritise technological interven-
tions that are available to reduce air pollution…”
The results are used to justify a conclusion that the
burden from air pollution “…cries out for the estab-
lishment of an inter-ministerial plan to identify and
implement those intervention strategies that are cost-
effective…” This call for strategies for air quality man-
agement in Israel assumes that the burden is too high
and can be reduced. Given that the models used for
burden estimation are linear without threshold, air
pollution will necessarily contribute to disease burden;
from the policy perspective, one complicated matter
is what level of burden is to be avoided through air
quality management and what residual burden that
cannot be controlled is acceptable? This is a societal
judgment that is generally made through precedent,
still lacking in Israel. The total calculated by Ginsberg
et al. of about 2000 deaths constitutes 4.7% of total
deaths in Israel in 2015, comparable to the GBD esti-
mate. They have judged that figure to warrant action.
Experience from the United States documents one
way to use the burden estimates for air quality regu-
lation. The calculations of avoidable burden have now
been incorporated into the process for revising the
NAAQS. In a multi-step process of evidence transla-
tion, a risk and exposure assessment is carried out to
estimate the extent to which potential changes in the
NAAQS would reduce burden and also the burden of
disease remaining if the revised NAAQS were
achieved [5]. In revising the NAAQS, the Administra-
tor of the Environmental Protection Agency considers
the public health benefits and the residual disease
burden for alternative values of the standard [10].
Costs do not figure directly in the Administrator’s de-
cision, raising the question as to how the results of a
“full cost-effectiveness analysis” would be used in
decision-making in Israel. Doing so would require
guidance on the parameters of cost-effectiveness suit-
able for the context of decision-making in Israel.
Conclusions
Israel does not yet have an evidence-based process for
air quality regulation comparable to that of the United
States, which has evolved over the 45 years since passage
of the Clean Air Act. In fact, Israel has only recently
promulgated a national standard for airborne particulate
matter and quantitative risk assessment has not been an
element of regulatory decision-making [11]. The report
by Ginsberg and colleagues represents a useful begin-
ning and should initiate a discussion of the role of bur-
den estimation and risk assessment more broadly in
regulations intended to advance environmental health in
Israel. The findings point to the need to set out on an
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